Bayer AG (BAYRY)
OTC: BAYRY
· Real-Time Price · USD
7.54
0.01 (0.13%)
At close: Jun 06, 2025, 3:59 PM
Bayer Income Statement
Financials in EUR. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 46.61B | 46.74B | 47.11B | 47.01B | 47.64B | 47.77B | 48.71B | 50.49B | 50.74B | 49.86B | 48.36B | 46.39B | 44.08B | 42.96B | 41.68B | 40.88B |
Cost of Revenue | 21.27B | 20.03B | 19.75B | 19.48B | 19.75B | 20.03B | 19.47B | 20.43B | 19.87B | 18.79B | 18.43B | 17.29B | 16.82B | 16.8B | 19.71B | 19.18B |
Gross Profit | 25.34B | 26.71B | 27.36B | 27.53B | 27.89B | 27.74B | 29.25B | 30.06B | 30.87B | 31.07B | 29.93B | 29.1B | 27.27B | 26.16B | 21.98B | 21.7B |
Operating Income | 3.89B | 3.29B | 3.62B | 1.75B | 1.59B | -496M | 4.23B | 5.35B | 6.53B | 7.28B | 6.58B | 4.12B | 3.01B | 18.37B | 8.45B | -58M |
Interest Income | 520M | 655M | 645M | 613M | 600M | 532M | 473M | 460M | 379M | 325M | 273M | 494M | 525M | 522M | 888M | 661M |
Pretax Income | -2.32B | -153M | -103M | -1.58B | -1.58B | -2.4B | 2.5B | 3.55B | 4.67B | 5.3B | 4.89B | 3.03B | 2.05B | 1.92B | -7.68B | -16.36B |
Net Income | -2.55B | -880M | -1.27B | -3.12B | -2.94B | -3.67B | 1.45B | 3.05B | 4.16B | 4.71B | 4.25B | 2.2B | 1B | 147M | -2.68B | -9.89B |
Selling & General & Admin | 15.41B | 14.45B | 14.32B | 14.29B | 14.71B | 15.77B | 16.24B | 17.03B | 16.92B | 16.79B | 16.47B | 15.75B | 15.32B | 14.53B | 15.69B | 15.62B |
Research & Development | 6.21B | 5.55B | 5.5B | 5.23B | 5.37B | 5.92B | 5.99B | 6.69B | 6.57B | 5.97B | 5.96B | 5.67B | 5.41B | 5.69B | 7.49B | 7.02B |
Other Expenses | -3.99B | -406M | n/a | n/a | 60M | -501M | -321M | 249M | 41M | -2.85B | -2.99B | -357M | -209M | -12.19B | -9.41B | -633M |
Operating Expenses | 17.63B | 19.59B | 23.84B | 25.9B | 26.53B | 27.57B | 24.28B | 23.97B | 23.54B | 19.91B | 19.44B | 21.06B | 20.36B | 7.86B | 13.6B | 21.83B |
Interest Expense | 2.36B | 2.72B | 2.89B | 2.84B | 2.67B | 2.24B | 2.08B | 2.14B | 2.2B | 2B | 1.69B | 1.46B | 1.35B | 1.48B | 1.51B | 1.38B |
Selling & Marketing Expenses | 13.36B | 12.6B | 12.5B | 12.33B | 12.48B | 13.35B | 13.65B | 14.19B | 14.08B | 13.88B | 13.54B | 12.77B | 12.36B | 11.69B | 12.97B | 12.91B |
Cost & Expenses | 38.9B | 39.63B | 43.59B | 45.38B | 46.28B | 47.6B | 43.74B | 44.4B | 43.41B | 38.7B | 37.87B | 38.35B | 37.17B | 24.66B | 33.31B | 41.01B |
Income Tax Expense | 212M | 667M | 1.1B | 1.49B | 1.32B | 1.28B | 1.05B | 500M | 504M | 570M | 625M | 807M | 1.02B | 1.68B | -125M | -1.52B |
Shares Outstanding (Basic) | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.92B | 3.93B |
Shares Outstanding (Diluted) | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B |
EPS (Basic) | -0.65 | -0.22 | -0.32 | -0.79 | -0.75 | -0.93 | 0.37 | 0.78 | 1.06 | 1.20 | 1.09 | 0.56 | 0.26 | 0.04 | -0.68 | -2.52 |
EPS (Diluted) | -0.65 | -0.22 | -0.32 | -0.79 | -0.75 | -0.93 | 0.37 | 0.78 | 1.06 | 1.20 | 1.09 | 0.56 | 0.26 | 0.04 | -0.68 | -2.52 |
EBITDA | 8.86B | 10.52B | 6.99B | 7.58B | 7.4B | 6.45B | 11.3B | 10.24B | 11.41B | 12.19B | 11.23B | 8.9B | 7.78B | 6.74B | 6.56B | -2.11B |
EBIT | 23M | 2.56B | 2.77B | 1.29B | 1.17B | 420M | 5.19B | 6.3B | 7.46B | 7.39B | 6.67B | 4.44B | 3.35B | 3.35B | -6.25B | -14.98B |
Depreciation & Amortization | 8.78B | 7.92B | 4.13B | 3.98B | 3.93B | 3.74B | 3.86B | 3.94B | 3.95B | 4.26B | 4.03B | 3.92B | 3.9B | 3.39B | 12.81B | 13.04B |